查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571806

先進眼科技術市場規模、佔有率和趨勢分析報告：按類型、最終用途、地區、細分市場預測，2024-2030 年

Advanced Ophthalmology Technology Market Size, Share & Trends Analysis Report By Type (Diagnostic, Therapeutic), By End Use (Hospitals, Ophthalmic Clinics, ASCs), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

先進眼科技術市場成長與趨勢：

預計2030年，全球先進眼科技術市場規模將達128.9億美元，2024年至2030年複合年成長率為7.5%。光同調斷層掃瞄掃描儀、鏡面顯微鏡、準分子雷射和飛秒雷射等各種眼科設備中頻繁採用先進眼科技術預計將推動整體市場的成長。

老年人口的不斷增加導致白內障、糖尿病性視網膜病變和近視等與老齡化。此類眼科疾病的日益普及正在推動眼科治療和先進眼科設備的採用。市場主要企業專注於採用先進技術，例如 SWEPT 來源 OCT、部分相干干涉測量 (PCI) 和 Polatest 技術。這些技術將有助於開發有效的眼科設備，以有效診斷和治療眼科疾病。

眼科超音波成像系統是最受青睞的先進眼科診斷設備之一，預計將大幅成長。與眼科超音波成像系統產業相比，光學超音波測量系統產業預計在預測期內也將穩定成長。這是因為光學生物測量提供了比超音波更準確的資料，並且技術的改進有助於測量晶狀體厚度、前房深度和其他眼軸長度參數。

2018年，手術設備在先進眼科治療設備中佔比最大。這是由於眼科手術的增加。主要的眼科手術器械是微型角膜刀和玻璃體視網膜手術器械。微型角膜刀主要用於LASIK和 ALK 手術。準分子雷射也是優選的先進眼科雷射之一。這是因為這些雷射在非常低的波長下產生非常小、精確的光斑。

先進眼科技術市場報告亮點

  • 由於主要市場參與者的存在、老齡化相關眼病患病率的增加以及先進眼科設備在美國的頻繁核准等因素，北美在 2023 年獲得了最大的市場佔有率。
  • 預計診斷領域將在 2023 年佔據主導市場佔有率，並呈現最快的成長速度。這是由於對眼部疾病早期診斷的需求不斷增加。
  • 光同調斷層掃瞄掃描儀是高度首選的先進眼科診斷設備，因為它們可以透過高解析度影像提供準確的結果。
  • 治療行業預計將呈現良好的成長率。預計眼科雷射在預測期內將以顯著的速度成長。這些雷射治療眼部疾病安全有效。
  • 由於門診手術中心為眼科護理手術提供優惠報銷，預計這些中心將呈現最快的成長速度。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章先進眼科技術市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 先進的眼科技術市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 先進眼科技術市場：類型估計與趨勢分析

  • 細分儀表板
  • 先進眼科技術市場：類型變化分析，2024年及2030年
  • 診斷
  • 治療

第5章先進眼科技術市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 先進眼科技術市場：最終用途變化分析，百萬美元，2024-2030
  • 醫院
  • 門診手術中心
  • 眼科診所

第6章先進眼科技術市場：區域估計與趨勢分析

  • 2024年及2030年按地區分類的先進眼科技術市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 最新趨勢與影響分析：主要市場參與企業
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Carl Zeiss Meditec AG
    • Bausch + Lomb.
    • Teva Pharmaceutical Industries Ltd.
    • CooperVision
    • Alcon
    • NIDEK CO., LTD.
    • TOPCON CORPORATION
    • Ziemer Ophthalmic Systems AG
    • Essilor International SA
簡介目錄
Product Code: GVR-3-68038-882-4

Advanced Ophthalmology Technology Market Growth & Trends:

The global advanced ophthalmology technology market size is expected to reach USD 12.89 billion in 2030 and is projected to grow at a CAGR of 7.5% from 2024 to 2030. Frequent introduction of advanced ophthalmology technologies incorporated in various ophthalmic devices such as optical coherence tomography scanner, specular microscopes, excimer lasers, and femtosecond lasers is expected to drive the overall market growth.

Rising geriatric population is contributing toward the growing prevalence of age-related ophthalmic disorders such as cataract, diabetic retinopathy, and myopia. This growing prevalence of ophthalmic disorders is boosting the adoption of ophthalmic treatments, and thus, advanced ophthalmic devices. Major players in the market are focusing on adopting advanced technologies such as SWEPT Source OCT, Partial coherence interferometry (PCI), and Polatest technology. These technologies will help in developing effective ophthalmic devices for efficient diagnosis and treatment of ophthalmic disorders.

Ophthalmic ultrasound imaging systems are one of the most preferred advanced ophthalmic diagnostic device and is expected to grow at a significant pace. The optical biometry systems segment is also expected to grow at steady rate during the forecast period in comparison to the ophthalmic ultrasound imaging systems segment. This is because optical biometry provides more accurate data in comparison to ultrasound as the refinements in its technology help in measuring lens thickness, anterior chamber depth, and other axial length parameters.

Surgical devices held the largest share among advanced ophthalmic therapeutic devices in 2018. This is because of the increasing number of ophthalmic surgeries. Major ophthalmic surgical devices are microkeratome and Vitreo retinal surgery devices. Microkeratome is largely preferred for LASIK and ALK surgery. Excimer lasers are also preferred as one of the advanced ophthalmic lasers because these lasers produce very small and precise spots at a very low wavelength.

Advanced Ophthalmology Technology Market Report Highlights:

  • North America captured the largest market share in 2023 owing to factors such as presence of major market players, growing prevalence of age-related ophthalmic disorders, and frequent approvals of advanced ophthalmic devices in the U.S.
  • The diagnostic segment held the dominant market share in 2023 and is expected to witness the fastest growth rate. This is because of the growing need for early diagnosis of ophthalmic disorders.
  • Optical coherence tomography scanners are highly preferred products under advanced diagnostic ophthalmic devices as these scanners provide accurate results via high resolution images.
  • The therapeutic segment is expected to showcase a lucrative growth rate. Ophthalmic lasers are expected to grow at a significant pace during the forecast period. These lasers are safe and effective in the treatment of ophthalmic disorders.
  • Ambulatory surgery centers are expected to exhibit the fastest growth rate owing to favorable reimbursement provided by these centers for ophthalmology procedures.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Advanced Ophthalmology Technology Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Advanced Ophthalmology Technology Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Advanced Ophthalmology Technology Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Advanced Ophthalmology Technology Market: Type Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Diagnostic
    • 4.3.1. Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Therapeutic
    • 4.4.1. Therapeutic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Advanced Ophthalmology Technology Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Advanced Ophthalmology Technology Market: End Use Movement Analysis, USD Million, 2024 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Ambulatory Surgical Centers
    • 5.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Ophthalmic Clinics
    • 5.5.1. Ophthalmic Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Advanced Ophthalmology Technology Market: Regional Estimates & Trend Analysis

  • 6.1. Advanced Ophthalmology Technology Market Share, By Region, 2024 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Advanced Ophthalmology Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Carl Zeiss Meditec AG
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Bausch + Lomb.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Teva Pharmaceutical Industries Ltd.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. CooperVision
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Alcon
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. NIDEK CO., LTD.
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. TOPCON CORPORATION
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Ziemer Ophthalmic Systems AG
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Essilor International S.A.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives